While IDH wild-type LGG closely resembles glioblastoma (GBM) in both molecular signatures and clinical behavior, often including PTEN, EGFR and NF1 mutations (Verhaak et al., 2010; Brennan et al., 2013). This evidence concerns the gene IDH1 and glioblastoma.